|
Occurrence of gametocytes as detected by microscopy or NASBA in the different study groups at the start of the study and during subsequent follow-up. |
|||||||
| Gametocyte positive samples |
Day 0 |
Day 1 |
Day 2 |
Day 3 |
Day 7 |
Day 14 |
Day 28 |
|
|
|||||||
| DP group microscopy (n = 67) |
|||||||
| Total number of positive cases |
3 |
7 |
7 |
10 |
7 |
5 |
0 |
| Number of new cases observed |
5 |
2 |
0 |
3 |
0 |
0 |
|
|
|
|||||||
| DP group Nasba (n = 56) |
|||||||
| Total number of positive cases |
22 |
34a |
33a |
17 |
8 |
||
| Number of new cases observed |
13 |
8 |
5 |
0 |
|||
|
|
|||||||
| AL group microscopy (n = 67) |
|||||||
| Total number of positive cases |
6 |
3 |
3 |
3 |
2 |
1 |
0 |
| Number of new cases observed |
1 |
1 |
0 |
1 |
0 |
0 |
|
|
|
|||||||
| AL group Nasba (n = 54) |
|||||||
| Total number of positive cases |
21 |
20 |
11 |
12 |
5 |
||
| Number of new cases observed |
6 |
4 |
6 |
0 |
|||
|
a Number of gametocyte carriers detected with NASBA is significantly higher in the DP treated group compared to the AL treated group. | |||||||
Mens et al. Malaria Journal 2008 7:237 doi:10.1186/1475-2875-7-237 |
|||||||